CRISPR Therapeutics AG (LON:0VRQ)
London · Delayed Price · Currency is GBP · Price in USD 56.70
-1.27 (-2.20%)
At close: Nov 5, 2025
CRISPR Therapeutics AG Market Cap
CRISPR Therapeutics AG has a market cap or net worth of 3.97 billion as of November 6, 2025. Its market cap has increased by 20.24% in one year.
Market Cap
3.97B
Enterprise Value
2.82B
Revenue
27.77M
Ranking
n/a
PE Ratio
n/a
Stock Price
56.70
Market Cap Chart
Since October 19, 2016, CRISPR Therapeutics AG's market cap has increased from 451.35M to 3.97B, an increase of 780.65%. That is a compound annual growth rate of 27.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 5, 2025 | 3.97B | 48.12% |
| Dec 31, 2024 | 2.68B | -31.26% |
| Dec 29, 2023 | 3.90B | 47.79% |
| Dec 30, 2022 | 2.64B | -38.32% |
| Dec 31, 2021 | 4.28B | -45.95% |
| Dec 31, 2020 | 7.92B | 189.80% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Oct 19, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 194.27B |
| HSBC Holdings | 184.59B |
| Shell | 164.07B |
| Unilever | 115.32B |
| Rolls-Royce Holdings | 96.56B |
| Rio Tinto Group | 90.02B |
| British American Tobacco p.l.c. | 87.25B |
| GSK plc | 70.63B |